The standard treatment for right heart failure includes aggressive fluid resuscitation, inotropic agents, and avoiding drugs, such as diuretics or nitrates, or maneuvers that decrease preload. Even an increase in vagal tone caused by the insertion of a bladder catheter can acutely decrease preload and lead to cardiogenic shock. Other modalities include early reperfusion therapy and pacemaker implantation for complete heart block or loss of atrioventricular synchrony. Acute right heart failure carries a very high mortality because of the limited options available for its management. Among newer treatments, inhaled nitric oxide and intravenous vasopressin have shown promise for acute right ventricular failure.
1. Eugene Braunwald. Heart Failure. Harrison Internal Medicine. McGraw-Hill, New York, pp 1036-1096, 2001
2.
2. Andersen HR, Falk E, Nielsen D. Right ventricular infarction: Frequency, size and topography in coronary heart disease: A prospective study comprising 107 consecutive autopsies from a coronary care unit. J Am Coll Cardiology10:1223-1232, 1987
3.
3. Goldstein J. Pathophysiology and management of right heart ischemia. J Am Coll Cardiol40:841-841, 2002
4.
4. Gaston B, Drazen JM, Loscalzo J, et al. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med149:538-551, 1994
5.
5. Nong Z, Hoylaerts M, Van Pelt N, et al. Nitric oxide inhalation inhibits platelet aggregation and platelet-mediated pulmonary thrombosis in rats. Circ Res81:865-869, 1997
6.
6. Rimar S, Gillis NC. Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation88:2884-2887, 1993
7.
7. Spalding MB, Ala-Kokk T, Kiviluoma K, et al. Inhaled nitric oxide effectively decreases right heart afterload following right heart infarct in pigs. Scand Cardiovasc J35:45-49, 2001
8.
8. Sitbon O, Brenot F, Denjean A, et al. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin. Am J Respir Crit Care Med151:38438-38439, 1995
9.
9. Leather HA, Segers P, Berends N, et al. Effects of vasopressin on the right ventricular function in an experimental model of acute pulmonary hypertension. Crit Care Med30:2604-2605, 2002
10.
10. Holmes CL, Patel BM, Russel JA, et al. Physiology of vasopressin relevant to management of septic shock. Chest120:989-1002, 2001
11.
11. Argenziano M, Choudhri AF, Oz MC, et al. A prospective randomized trial of Arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation96:286-290, 1997
12.
12. Helman DN, Oz MC. Developing a comprehensive mechanical support program. J Cardiac Surg16:203-208, 2001
